Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus

被引:14
作者
Elsehmawy, Asmaa Abd El Wakeel [1 ]
El-Toukhy, Safinaz Ebrahim [2 ]
Seliem, Nora Mohamed Ahmed [3 ]
Moustafa, Rehab Selim [4 ]
Mohammed, Doaa Sayed [5 ]
机构
[1] Al Azhar Univ, Dept Pediat, Fac Med, Nerco Tower 5, Cairo, Egypt
[2] Natl Res Ctr, Dept Med Biochem, Cairo, Egypt
[3] Al Azhar Univ, Biochem Dept, Fac Med, Cairo, Egypt
[4] Natl Res Ctr, Child Hlth Dept, Cairo, Egypt
[5] Al Azhar Univ, Endocrine Dept, Fac Med, Cairo, Egypt
关键词
apelin; chemerin; children; diabetes mellitus; NEPHROPATHY; DYSFUNCTION; LIPOLYSIS; SYSTEM;
D O I
10.2147/DMSO.S189264
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 1 diabetes mellitus (T1DM) is one of the most common chronic diseases in children that may be due to micro or macrovascular complications. Diabetic renal disease or nephropathy is a common complication of DM, clinically silent and the only detectable abnormality due to the presence of microalbuminuria. Subjects and methods: This study was a case-control study. Participants were classified into two groups. The first group included 40 children with T1DM and the second group included 30 matched healthy controls. Serum apelin (APLN), chemerin, cholesterol, and triglycerides (TG) levels were measured for each case. Also, albumin/creatinine ratio was analyzed in random urine sample. Results: Comparison between T1DM patients and controls revealed that serum apelin, chemerin, cholesterol, TG levels, and albuminuria were significantly increased in cases compared to their controls. Significant positive correlations were found between HbA1c% and albuminuria for APLN and chemerin in the diabetic group. Whereas significant negative correlations were found between apelin and glomerular filtration rate (GFR). Conclusion: Increased levels of serum apelin and chemerin in T1DM patients may be considered as promising adipokines for the development of diabetic complication.
引用
收藏
页码:383 / 389
页数:7
相关论文
共 32 条
[1]  
ALSuhaimi E. A., 2012, OPEN ENDOCRINOL J, V6, P110
[2]  
American Diabetes Association, 2013, DIABETES CARE, V35, P64
[3]   Introduction [J].
不详 .
DIABETES CARE, 2015, 38 :S1-S2
[4]   Chemerin, a Novel Adipokine in the Regulation of Angiogenesis [J].
Bozaoglu, Kiymet ;
Curran, Joanne E. ;
Stocker, Claire J. ;
Zaibi, Mohamed S. ;
Segal, David ;
Konstantopoulos, Nicky ;
Morrison, Shona ;
Carless, Melanie ;
Dyer, Thomas D. ;
Cole, Shelley A. ;
Goring, Harald H. H. ;
Moses, Eric K. ;
Walder, Ken ;
Cawthorne, Michael A. ;
Blangero, John ;
Jowett, Jeremy B. M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05) :2476-2485
[5]  
Burtis C A., 1994, Tietz textbook of clinical chemistry, V2nd, P1017
[6]  
Dawood A, 2017, EGYPT J OBES DIABETE, V3, P32
[7]  
Dayem Soha M Abd El, 2017, Open Access Maced J Med Sci, V5, P934, DOI 10.3889/oamjms.2017.204
[8]   Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus [J].
Demirel, Fatma ;
Tepe, Derya ;
Kara, Ozlem ;
Esen, Ihsan .
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2013, 5 (03) :145-149
[9]  
El-Gohary IE., 2016, AM J INTERNAL MED, V4, P13
[10]  
FLEGG H M, 1973, Annals of Clinical Biochemistry, V10, P79, DOI 10.1177/000456327301000125